DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 295 participants.

Also called NCT03494920

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 295 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03494920
Other papers using this trial's data
  • Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial Lancet (London, England), 2022-07-09 DOI, PubMed 35810757

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia, China, Singapore, Vietnam (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03494920. Randomized; single masking; primary purpose treatment. Start 2018-04-27 (actual); primary completion 2021-09-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval
Intervention (Other)
Direct endovascular clot retrieval
Intervention (Other)
Bridging thrombolysis followed by ECR
Lead sponsor
Neuroscience Trials Australia (class: other)
Collaborator
The Florey Institute of Neuroscience and Mental Health (class: other)

Record details

Record id
cardio:ct-nct03494920
Content hash
7afbd12f10574b625d36303328af23b28158eb5af211e22cba675b8d974f402f